|
LIVER VOLUME REDUCTION IN RESMETIROM TREATED NON-CIRRHOTIC AND CIRRHOTIC NASH PATIENTS
 
|
|
|
AASLD Nov 2021  
Dr. Mustafa Bashir, Duke University; Ms. Sarah Cubberly, Duke University; Ms. Aalanah Valentine, Duke University; Ms. Kassi Sollace, Duke University; Dr. Brandon Konkel, Duke University; Dr. Rebecca A. Taub, Madrigal Pharmaceuticals; Dr. Stephen A. Harrison, Radcliffe Department of Medicine, University of Oxford  
Hepatomegaly is enlargement of the liver beyond its normal size. Certain conditions such as infection, parasites, tumors, anemias, toxic states, storage diseases, heart failure, congenital heart disease, and metabolic disturbances may all cause an enlarged liver.
| |
|
|
|
|
|